Compound Detail
CHEMBL2107726
ARIMOCLOMOL 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL2107726 |
| Name | ARIMOCLOMOL |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | SGEIEGAXKLMUIZ-XUVDNFPMSA-N |
| Therapeutic | ✓ Yes |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
2
Publications
2
Known Names
4
Indications
Molecular Properties
313.8
MW (Da)
1.08
ALogP
5
HBA
1
HBD
72.0
PSA (Ų)
0.37
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2024 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Amyotrophic Lateral Sclerosis Myositis, Inclusion Body Gaucher Disease Niemann-Pick Disease, Type C
ATC Classification
N07XX17
arimoclomol
Level 1: NERVOUS SYSTEM
Level 2: OTHER NERVOUS SYSTEM DRUGS
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 23458846 | 10.1021/jm3015926 | Mus musculus | 1 |
| 27372371 | 10.1016/j.ejmech.2016.06.017 | Superoxide dismutase [Cu-Zn] | 1 |
Data from ChEMBL 36 via Core Engine